Search

everythinglearnresearchcommunity

for

Search:↓

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Japanese women typically start experiencing hair loss after 40, with reduced hair density and thickness being the main factors.

The circadian clock influences the behavior and regeneration of stem cells in the body.

Aging mice have slower hair regeneration due to changes in signal balance, but the environment, not stem cell loss, controls this, suggesting treatments could focus on environmental factors.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

The HR protein's role as a repressor is essential for controlling hair growth.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Triparanol therapy can cause hair loss and skin dryness without inflammation or damage to hair follicles or skin structures.

Prolactin affects when mice shed and grow hair.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Wnt signaling is crucial for skin and hair development and its disruption can cause skin tumors.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Human hair follicles can regenerate after removal, but with low success rate.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

HFMs can help study hair growth and test potential hair growth drugs.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.